Wednesday, July 8, 2026

pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB

ASSEMBLY BIOSCIENCES

ASSEMBLY BIOSCIENCES clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
Status
Public
HQ
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
Founded
2014
Employees
99
Programs
15
Drugs
10
Patents
14
Intelligence · Clinical Programs

ASSEMBLY BIOSCIENCES projects

3 ClinicalTrials.gov programs sponsored by ASSEMBLY BIOSCIENCES.

ASSEMBLY BIOSCIENCES has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ABI-H0731

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    6 trials
  2. VBR

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    1 trial
  3. standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI)

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does ASSEMBLY BIOSCIENCES have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.